{"text": "$pfe: pfizer's phase 3 octave studies of oral tofacitinib in ulcerative colitis results were published in the new... URL"}
{"text": "$pfe pfizer's phase 3 octave studies of oral tofacitinib in ulcerative colitis results were published in the new \u00a1\u00ad URL"}
{"text": "weak xtandi sales spur questions on $pfe's $14b medivation takeover URL"}
{"text": "american trust investment advisors llc sells 435 shares of pfizer inc. $pfe URL"}
{"text": "rt AT_USER pfizer must face nyu in a lawsuit over one of its cancer drugs, again.. read why here URL #pharma $pfe #\u00a1\u00ad"}
{"text": "rt AT_USER pfizer must face nyu in a lawsuit over one of its cancer drugs, again.. read why here URL #pharma $pfe #\u00a1\u00ad"}
{"text": "rt AT_USER pfizer must face nyu in a lawsuit over one of its cancer drugs, again.. read why here URL #pharma $pfe #\u00a1\u00ad"}
{"text": "get back out there, pfizer URL AT_USER via AT_USER $pfe URL"}
{"text": "rt AT_USER pfizer must face nyu in a lawsuit over one of its cancer drugs, again.. read why here URL #pharma $pfe #\u00a1\u00ad"}
{"text": "with #pfizer's xtandi sales slowing, analysts question $14b medivation price. read more: URL $pfe"}
{"text": "pfizer must face nyu in a lawsuit over one of its cancer drugs, again.. read why here URL #pharma $pfe #cancer #patents"}
{"text": "weekly investment analysts\u00a1\u00af ratings changes for pfizer $pfe URL"}
{"text": "weekly investment analysts\u00a1\u00af ratings changes for pfizer $pfe URL"}
{"text": "pfizer inc. $pfe sees significant decrease in short interest URL"}
{"text": "bristol-myers \"too risky\" to acquire as merck, roche pile on pressure $bmy $mrk $rhhby $incy $pfe URL"}
{"text": "moody's affirms costco's a1 rating URL $cost $sbux $tgt $wmt $hd $nke $ko $pg $jnj $xom $amgn $pfe $mrk $low $dis $aapl"}
{"text": "don't count us out: pfizer $pfe hints at a possible bristol-myers squibb $bmy deal URL URL"}
{"text": "rt AT_USER with pfizer\u00a1\u00afs xtandi sales slowing, analysts question that $14b medivation price URL $pfe"}
{"text": "#prostatecancer diagnostics is a $12b industry. this new diagnostic could be a game-changer. $mrk $pfe $bmy $lly  URL"}
{"text": "barronsonline: bristol-myers: going stag to the ball? URL $bmy $pfe $gild $nvs URL"}
{"text": "rt AT_USER bristol-myers: going stag to the ball? URL $bmy $pfe $gild $nvs URL"}
{"text": "bristol-myers: going stag to the ball? URL $bmy $pfe $gild $nvs URL"}
{"text": "pfizer dividend remains attractive after q1 earnings $pfe #pharma #pfizer #stocks #finance #dividends #earnings  URL"}
{"text": "2017 establishes eliquis as the blood-thinner to beat URL $bayry $jnj $bmy $pfe"}
{"text": "2017 establishes eliquis as the blood-thinner to beat URL $bayry $jnj $bmy $pfe"}
{"text": "#pfizer announces u.s. fda filing acceptance of supplemental new drug application for xeljan... read more: URL $pfe"}
{"text": "weekly investment analysts\u00a1\u00af ratings changes for pfizer $pfe URL"}
{"text": "rt AT_USER strap on your parachutes, pharma faces a mini patent cliff.. how bad? read here.. URL #pharma $mrk $pfe\u00a1\u00ad"}
{"text": "pfizer, bms' eliquis takes j&amp;j's next-gen anticoagulant market-share crown: URL $pfe $bmy $jnj #pharma #marketing"}
{"text": "rt AT_USER with pfizer\u00a1\u00afs xtandi sales slowing, analysts question that $14b medivation price: URL $pfe #pharma"}
{"text": "rt AT_USER with pfizer\u00a1\u00afs xtandi sales slowing, analysts question that $14b medivation price: URL $pfe #pharma"}
{"text": "with #pfizer's xtandi sales slowing, analysts question that $14b medivation price. read more: URL $pfe"}
{"text": "#barclays on $pfe #pfizer after the q1'17 call -URL"}
{"text": "with pfizer\u00a1\u00afs xtandi sales slowing, analysts question that $14b medivation price: URL $pfe #pharma"}
{"text": "$fbio  way under valued should be 8-9$ imo massive pipeline subsids majority owned $fb $amgn $bmy $pfe $regn $sny $espr $amrn $teva $auph"}
{"text": "#pfizer announces u.s. fda filing acceptance of supplemental new drug application for xeljan... read more: URL $pfe"}
{"text": "salphatrending: assessing gilead's positives and negatives URL $abbv $alioy $alxn $celg $ibb $jnj $mrk $pfe $spy $gild"}
{"text": "assessing gilead's positives and negatives URL $abbv $alioy $alxn $celg $ibb $jnj $mrk $pfe $spy $gild"}
{"text": "$pfe barclays sets pt at $38 URL"}
{"text": "assessing gilead's positives and negatives URL $abbv $alioy $alxn $celg $ibb $jnj $mrk $pfe $spy $gild"}
{"text": "with pfizer\u00a1\u00afs xtandi sales slowing, analysts question that $14b medivation price URL $pfe"}
{"text": "assessing gilead's positives and negatives URL $abbv $alioy $alxn $celg $ibb $jnj $mrk $pfe $spy $gild"}
{"text": "assessing gilead's positives and negatives URL $abbv $alioy $alxn $celg $ibb $jnj $mrk $pfe $spy $gild"}
{"text": "best dj stock for capital gain in next 3 months URL $csco #cisco $v $hd $msft $gs $unh $dd $pfe $jpm $mmm $ge $nke"}
{"text": "pfizer inc. $pfe releases fy17 earnings guidance URL"}
{"text": "best dj stock for capital gain in next 3 months URL $csco #cisco $v $hd $msft $gs $unh $dd $pfe $jpm $mmm $ge $nke"}
{"text": "best dj stock for capital gain in next 3 months URL $csco #cisco $v $hd $msft $gs $unh $dd $pfe $jpm $mmm $ge $nke"}
{"text": "rt AT_USER bristol-myers cut to sell with pfizer takeover seen as unlikely $bmy $pfe $mrk URL"}
{"text": "pfizer inc. $pfe releases fy17 earnings guidance URL"}
{"text": "#pfizer announces u.s. fda filing acceptance of supplemental new drug application for xeljan... read more: URL $pfe"}
{"text": "#pfizer beats 1q profit forecasts, but sales dip misses views. read more: URL $pfe"}
{"text": "pfizer given $38.00 pt by barclays plc. buy rating. URL $pfe #pfe"}
{"text": "pfizer given $38.00 pt by barclays plc. buy rating. URL $pfe #pfe"}
{"text": "pfizer dividend remains attractive after q1 earnings URL $pfe"}
{"text": "so what\u00a1\u00afs holding back pfizer $pfe and gilead $gild from the really big deals we\u00a1\u00afve all been waiting for? - URL #pharma"}
{"text": "pfizer dividend remains attractive after q1 earnings URL $pfe"}
{"text": "pfizer dividend remains attractive after q1 earnings URL $pfe"}
{"text": "#pfizer, bms' eliquis takes j&amp;j's next-gen anticoagulant market-share crown . read more: URL $pfe"}
{"text": "bristol-myers cut to sell with pfizer takeover seen as unlikely $bmy $pfe $mrk URL"}
{"text": "don't count us out: #pfizer hints at a possible bristol-myers squibb deal  . read more: URL $pfe"}
{"text": "bristol-myers cut to sell with #pfizer takeover seen as unlikely $bmy $pfe URL"}
{"text": "pfizer, bms' eliquis takes j&amp;j's next-gen anticoagulant market-share crown URL $pfe $bmy $jnj"}
{"text": "#icymi: is pfizer really weighing a bms buy? clues from q1's earnings call say it just may be URL $pfe $bmy #pharma"}
{"text": "medtech[y] |pfizer earnings results and earnings call slides $pfe URL AT_USER"}
{"text": "#pfizer announces u.s. fda filing acceptance of supplemental new drug application for xeljan... read more: URL $pfe"}
{"text": "$pfe fda has accepted for review the snda for xeljanz 5 mg twice daily for the treatment of adult patients with ac\u00a1\u00ad URL"}
{"text": "$ko $mcd $mmm $mrk $msft $nke $pfe long and short positions from the dow jones, up to 1800% since 2008. URL $djia $dia"}
{"text": "$pfe pfizer announces u.s. fda filing acceptance of supplemental new drug application... URL"}
{"text": "$pfe q1 2017 earnings call audio is now available #earnings URL"}
{"text": "$pfe pfizer announces u.s. fda filing acceptance of supplemental new drug application for xeljanz(r) (tofacitinib citrate)"}
{"text": "pfizer ceo wants clarity on tax, healthcare reform before doing megadeals URL $pfe URL"}
{"text": "$pfe got an upgrade today. will they buy or cry. finicky traders"}
{"text": "$pfe ceo mentioning certain large companies have binaries ahead. clearly referring to $bmy's pd1 combos URL"}
{"text": "origin asset management llp sells 5,400 shares of pfizer inc. $pfe URL"}
{"text": "pfizer inc. $pfe posts quarterly earnings results, beats estimates by $0.02 eps URL"}
{"text": "AT_USER that might have been a shakeout candle yesterday on $pfe."}
{"text": "AT_USER AT_USER yikes! one would have thought it possible that, finally, $pfe had decided enough was enough w/ mega-m&amp;a"}
{"text": "#pfizer earnings prompt calls for deal-making. read more: URL $pfe"}
{"text": "31,835 shares in pfizer inc. $pfe acquired by access financial services inc. URL"}
{"text": "31,835 shares in pfizer inc. $pfe acquired by access financial services inc. URL"}
{"text": "31,835 shares in pfizer inc. $pfe acquired by access financial services inc. URL"}
{"text": "31,835 shares in pfizer inc. $pfe acquired by access financial services inc. URL #stocks"}
{"text": "patriot financial group insurance agency llc purchases shares of 11,487 pfizer inc. $pfe URL"}
{"text": "patriot financial group insurance agency llc purchases shares of 11,487 pfizer inc. $pfe URL"}
{"text": "vident investment advisory llc sells 24,718 shares of pfizer inc. $pfe URL"}
{"text": "complexica wins tender to provide ai software for #pfizer australia . read more: URL $pfe"}
{"text": "impact of #biosimilars on q1 sales. $pfe enbrel down $134 m (28% in eu); $mrk remicade down $120m (34% principally eu)"}
{"text": "rt AT_USER $pfe repurchased ~ 126m shares for $5b in q1."}
{"text": "tenet #healthcare corp. $thc jumps a whopping +21.56%today! see vista partners #growth #stocks\u00a1\u00ad URL"}
{"text": "rt AT_USER #pfizer world-wide sales for #xalkori was 142m usd in q1 2017 (up 2%) $pfe URL"}
{"text": "rt AT_USER apple watch: all eyes on iphone maker, but don\u00a1\u00aft forget auto sales, fed mtg URL via AT_USER $a\u00a1\u00ad"}
{"text": "pfizer $pfe receives media impact rating of 0.09 URL"}
{"text": "i like it here. pharma picking up momentum. i also see natalie's point as well. $pfe URL"}
{"text": "flurry of fda activity raises hopes for 2017 approval tally URL $azn $bmrn $tkphf $tkpyy $lly $incy $rdus $pfe $nvs"}
{"text": "what a daily candle on $pfe. closing &gt; 200 ma after eps today. large cap pharma look good. any interest in $pfe here?AT_USER AT_USER"}
{"text": "flurry of fda activity raises hopes for 2017 approval tally URL $azn $bmrn $tkphf $tkpyy $lly $incy $rdus $pfe $nvs"}
